Articles

RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes

Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU) Munich, Munich;Clinical Cooperative Group ‘Leukemia’, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich
Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU) Munich, Munich;Clinical Cooperative Group ‘Leukemia’, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich
Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU) Munich, Munich
Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU) Munich, Munich
Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU) Munich, Munich
Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU) Munich, Munich
Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU) Munich, Munich
Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU) Munich, Munich
Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU) Munich, Munich
Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU) Munich, Munich;Clinical Cooperative Group ‘Leukemia’, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich;Center for Human Genetics, Philipps Universität, Marburg, Germany
Oncology and Hematology, St. John-of-God Hospital, Regensburg
Institute of Biostatistics and Clinical Research
Department of Medicine A-Hematology, Oncology and Pneumology, Universität Münster, Münster
Department of Medicine A-Hematology, Oncology and Pneumology, Universität Münster, Münster
German Society of Hematology and Oncology, Berlin
Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU) Munich, Munich;Clinical Cooperative Group ‘Leukemia’, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich
Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU) Munich, Munich;Clinical Cooperative Group ‘Leukemia’, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich
Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU) Munich, Munich;Clinical Cooperative Group ‘Leukemia’, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich;Center for Human Genetics, Philipps Universität, Marburg, Germany
Vol. 97 No. 12 (2012): December, 2012 https://doi.org/10.3324/haematol.2012.064667